A record number of people are now on antiretroviral therapy, but a similar number are still awaiting treatment.
During the past decade, the collective efforts of activists, researchers, service providers, pharmaceutical companies, policymakers, and international agencies have generated real momentum in scaling up HIV treatment and prevention across the globe, with special emphasis on Africa. The successes have been immense, but so too the challenges.
Successes
In July 2000, diverse groups from around the world joined forces at the 13th International AIDS Conference in Durban, South Africa, to demand global access to HIV treatment. Shortly thereafter, the Global Fund to Fight AIDS, Tuberculosis and Malaria was conceived, followed by the U.S. President's Emergency Plan for AIDS Relief. Since then, the number of people receiving antiretroviral therapy (AR…
Author
DisclosuresConsultant/Advisory BoardUNAIDS; WHO; Bill and Melinda Gates Foundation, Population Council
Grant/Research SupportNIH; National Institute of Allergy and Infectious Diseases; Tides Foundation/MAC AIDS Fund; USAID; South African National Research Foundation; European Union; South African Medical Research Council
Editorial BoardsNew England Journal of Medicine; AIDS Reviews; AIDS Research and Human Retroviruses; mBio; Indian Journal of Medical Research; JAIDS: Journal of Acquired Immune Deficiency Syndromes
DisclosuresConsultant/Advisory BoardUNAIDS; WHO; Bill and Melinda Gates Foundation, Population Council
Grant/Research SupportNIH; National Institute of Allergy and Infectious Diseases; Tides Foundation/MAC AIDS Fund; USAID; South African National Research Foundation; European Union; South African Medical Research Council
Editorial BoardsNew England Journal of Medicine; AIDS Reviews; AIDS Research and Human Retroviruses; mBio; Indian Journal of Medical Research; JAIDS: Journal of Acquired Immune Deficiency Syndromes